Результаты лечения больных раком мочевого пузыря с метастазами в регионарных лимфоузлах

1. Мавричев А.С., Красный С.А., Поляков С.Л. и др. Онкоурология. Минск, БелЦНМИ; 2001.

2. Матвеев Б.П., Фигурин К.М., Карякин О.Б. Рак мочевого пузыря. М., Вердана; 2001.

3. Busby J.E., Evans C.P. Old friends, new ways: revisiting extended lymphadenectomy and neoadjuvant chemotherapy to improve outcomes. Curr Opin Urol 2004;14:251—7.

4. Campbell's Urology. 8th ed. P.C. Walsh, A.B. Retik, E.D. Vaughan and A. J. Wein (eds). Philadelphia, W.B. Saunders Co; 2002.

5. Herr H.W. The natural history of a T1 bladder cancer: life-long tumour diathesis. BJU Int 1999;84:1102—3.

6. Solsona E., Iborra I., Dumont R. et al. Risk groups in patients with bladder cancer treated with radical cystectomy: statistical and clinical model improving homogeneity. J Urol 2005;174:1226—30.

7. Stein J.P., Lieskovsky G., Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001;19:666—775.

8. Hautmann R.E., Stein J.P. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: A step in the wrong direction. Urol Clin North Am 2005;32(2):177—85.

9. Stenzl A., Nagele U., Kuczyk M. et al. Cystectomy — technical considerations in male and female patients. EAU Update Series 2005;(3):138—46.

10. Hoshi S., Orikasa S., Suzuki K. et al. Diagnosis and treatment of pelvic lymph node metastasis in bladder cancer. Int J Urol 1999;6:400—7.

11. Shvarts O., Han K.R., Seltzer M. et al. Positron emission tomography in urologic oncology. Cancer Control 2002;9:335—42.

12. Madersbacher S., Hochreiter W., Burkhard F.H. et al. Radical cystectomy for bladder cancer today a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003;21:690—6.

13. Liedberg F., Mansson W. Lymph node metastasis in bladder cancer. Eur Urol 2006;49:13—21.

14. Stein J.P., Quek M.L., Skinner D.G. Lymphadenectomy for invasive bladder cancer: II. historical perspective and contemporary rationale. BJU Int 2006;97:232—7.

15. Stein J.P., Quek M.L., Skinner D.G. Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale. BJU Int 2006;97:227—31.

16. Herr H.W. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003;169:943—5.

17. Bochner B.H., Herr H.W., Reuter V.E. Impact of separate versus en block pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol 2001;169:2295—6.

18. Bochner B.H., Cho D., Herr H.W. et al. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004;172:1286—90.

19. Ather M.H., Fatima S., Sinanoglu O. Extent of lymphadenectomy in radical cystectomy for bladder cancer. World J Surg Oncol 2005;43(3):1—5.

20. Leissner J., Ghoneim M.A. Abol-Enein H. et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J Urol 2004;171: 139—44.

21. Brössner C., Pycha A., Toth A. et al. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 2004;93:64—6.

22. Frank I., Cheville J.C., Blute M.L. et al. Transitional cell carcinoma of the urinary bladder with regional lymph node involvement treated by cystectomy: clinicopathologic features associated with outcome. Cancer 2003;97:2425—30.

23. Knap M.M., Lundbeck F., Overgaard J. The role of pelvic lymph node dissection as a predictive and prognostic factor in bladder cancer. Eur J Cancer 2003;39:604—13.

24. Stein J.P., Cai J., Groshen S., Skinner D.G. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en block pelvic lymphadenectomy: the concept of lymph node density. J Urol 2003;170:35—41.

25. Fleischmann A., Thalmann G.N., Markwalder R., Studer U.E. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder. Am J Surg Pathol 2005;29:89—95.

26. Sanderson K.M., Stein J.P., Skinner D.G. The evolving role of pelvic lymphadenectomy in the treatment of bladder cancer. Urol Oncol 2004;22:205—13.

27. Herr H.W. Surgical factors in bladder cancer: more (nodes) + more (pathology) = less (mortality). BJU Int 2003;92:187—8.

28. Konety B.R., Joslyn S.A. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol 2003;170:1765—71.

29. Herr H.W., Faulkner J.R., Grossman H.B.R. et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004;22:2781—5.

30. Lebret T., Herve J.M., Yonneau L. et al. After cystectomy, is it justified to perform a bladder replacement for patients with lymph node positive bladder cancer? Eur Urol 2002;42:344—9.

31. Shekarriz B., Pontes J.E. Management of poor risk patients with muscleinvasive transitional cell carcinoma of the bladder. AUA Update Series 2001;20:90—5.

32. Nishiyama H., Habuchi T., Watanabe J. et al. Clinical outcome of a largescale multi-institutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990—2000 in Japan. Eur Urol 2004;45:176—81.